Conversely, anhidrosis, or reduced or absent sweating, is less common but may be experienced in the feet or legs of people with diabetic neuropathy. Treatment of excessive sweating depends on the ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

Ionis Pharmaceuticals IONS announced that the European Commission (“EC”) has approved Wainzua (eplontersen) for treating ...

Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...